BrightGene Bio-Medical Technology Co Ltd
SSE:688166

Watchlist Manager
BrightGene Bio-Medical Technology Co Ltd Logo
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
Watchlist
Price: 30.2 CNY 1.82% Market Closed
Market Cap: 12.8B CNY
Have any thoughts about
BrightGene Bio-Medical Technology Co Ltd?
Write Note

Relative Value

The Relative Value of one BrightGene Bio-Medical Technology Co Ltd stock under the Base Case scenario is 28.41 CNY. Compared to the current market price of 30.2 CNY, BrightGene Bio-Medical Technology Co Ltd is Overvalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
28.41 CNY
Overvaluation 6%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
51
vs Industry
13
Median 3Y
9.8
Median 5Y
11.6
Industry
2.5
Forward
9.6
vs History
35
vs Industry
5
Median 3Y
49.6
Median 5Y
66.8
Industry
21.4
Forward
58.8
vs History
54
vs Industry
10
Median 3Y
47.2
Median 5Y
67.7
Industry
16
vs History
vs Industry
4
Median 3Y
19.6
Median 5Y
19.6
Industry
23.3
vs History
54
vs Industry
13
Median 3Y
5.2
Median 5Y
6.2
Industry
2.1
vs History
50
vs Industry
12
Median 3Y
10.4
Median 5Y
12.1
Industry
2.6
Forward
10.5
vs History
50
vs Industry
9
Median 3Y
17.9
Median 5Y
21.9
Industry
5.1
vs History
32
vs Industry
5
Median 3Y
48.8
Median 5Y
59.7
Industry
13.7
Forward
37.5
vs History
32
vs Industry
6
Median 3Y
48.8
Median 5Y
59.7
Industry
16.7
Forward
49.1
vs History
51
vs Industry
9
Median 3Y
51.5
Median 5Y
72.6
Industry
15.1
vs History
vs Industry
Median 3Y
-58
Median 5Y
-65.2
Industry
18.9
vs History
56
vs Industry
22
Median 3Y
3.3
Median 5Y
4.1
Industry
1.9

Multiples Across Competitors

Competitors Multiples
BrightGene Bio-Medical Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
12.7B CNY 10.3 67.8 67.8 67.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
726.7B USD 17.8 86.8 46.7 52.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.1 28.8 20 22.9
US
Johnson & Johnson
NYSE:JNJ
345.8B USD 3.9 23.6 11.4 14.8
US
Merck & Co Inc
NYSE:MRK
252.5B USD 4 20.8 10.5 12.6
CH
Roche Holding AG
SIX:ROG
205.3B CHF 3.5 17.9 10 11.9
UK
AstraZeneca PLC
LSE:AZN
166.1B GBP 4.2 32.3 169.7 254.3
CH
Novartis AG
SIX:NOVN
174B CHF 3.9 10.9 9.5 13.2
US
Pfizer Inc
NYSE:PFE
152.4B USD 2.5 35.8 10.6 16.1
P/E Multiple
Earnings Growth PEG
CN
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
Average P/E: 36.1
67.8
16%
4.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
86.8
76%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
28.8
23%
1.3
US
Johnson & Johnson
NYSE:JNJ
23.6
-8%
N/A
US
Merck & Co Inc
NYSE:MRK
20.8
320%
0.1
CH
Roche Holding AG
SIX:ROG
17.9
16%
1.1
UK
AstraZeneca PLC
LSE:AZN
32.3
40%
0.8
CH
Novartis AG
SIX:NOVN
10.9
9%
1.2
US
Pfizer Inc
NYSE:PFE
35.8
102%
0.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
Average EV/EBITDA: 420.3
67.8
31%
2.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
46.7
42%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
DK
Novo Nordisk A/S
CSE:NOVO B
20
22%
0.9
US
Johnson & Johnson
NYSE:JNJ
11.4
4%
2.9
US
Merck & Co Inc
NYSE:MRK
10.5
63%
0.2
CH
Roche Holding AG
SIX:ROG
10
7%
1.4
UK
AstraZeneca PLC
LSE:AZN
169.7
18%
9.4
CH
Novartis AG
SIX:NOVN
9.5
3%
3.2
US
Pfizer Inc
NYSE:PFE
10.6
9%
1.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
Average EV/EBIT: 1 816.8
67.8
18%
3.8
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
52.1
45%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
DK
Novo Nordisk A/S
CSE:NOVO B
22.9
22%
1
US
Johnson & Johnson
NYSE:JNJ
14.8
9%
1.6
US
Merck & Co Inc
NYSE:MRK
12.6
98%
0.1
CH
Roche Holding AG
SIX:ROG
11.9
9%
1.3
UK
AstraZeneca PLC
LSE:AZN
254.3
32%
7.9
CH
Novartis AG
SIX:NOVN
13.2
17%
0.8
US
Pfizer Inc
NYSE:PFE
16.1
19%
0.8